X. Li

Intravenous neutralization of vascular endothelial growth factor reduces vascular function/permeability of the ovary and prevents development of OHSS-like symptoms in rhesus monkeys

O. Slayden, C. Bishop, D. Lee, 2017, Journal of Ovarian Research.

Measurement of leukemia inhibitory factor in biological fluids by radioimmunoassay.

G. Braunstein, S. Melmed, S. Ren, 1998, The Journal of clinical endocrinology and metabolism.

The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Angiogenic Growth Factor Messenger Ribonucleic Acids in Uterine Natural Killer Cells*

D. Charnock-Jones, Stephen K. Smith, J. Bowen, 2022 .

The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society In Vivo and in Vitro Regulation of Thyroid Leukemia Inhibitory Factor (LIF): Marker of Hypothyroidism*

G. Braunstein, S. Melmed, S. Ren, 2022 .

Neutralization of vascular endothelial growth factor (VEGF) before or after CG during COS cycles restores ovarian vascular parameters similar to natural menstrual cycles: a pilot study in nonhuman primates

David M. Lee, C. Bishop, X. Li, 2015 .